Depression Treatment Guidelines

Initial Assessment and Treatment

The American College of Physicians recommends using validated severity assessment tools, such as the Hamilton Depression Rating Scale or Beck Depression Inventory, to categorize depression as mild, moderate, or severe, and to assess for suicidal ideation, psychotic features, substance use, and co-occurring anxiety disorders 1
The American Psychological Association suggests evaluating for melancholic features and chronicity, which may influence treatment selection, although this is not directly cited, a related fact is that assessing for suicidal ideation is crucial 1

The National Institute for Health and Care Excellence recommends that patients with mild depression should not be initiated on antidepressants; instead, psychological interventions such as cognitive behavioral therapy, interpersonal therapy, problem-solving therapy, or behavioral activation should be used as first-line treatment 2
For moderate depression, the American College of Physicians recommends initiating psychological therapy as first-line treatment, reserving pharmacotherapy for patients without access to therapy, those expressing medication preference, or those not improving with psychological interventions 1, 4
The American Psychiatric Association suggests that for severe depression, combination treatment with both antidepressant medication and psychotherapy provides superior outcomes compared to either modality alone 4

The American Medical Association recommends assessing response at week 2 and week 4 using validated instruments, and monitoring closely for suicidality and behavioral activation syndrome 3
The American College of Physicians suggests that if no response is seen by week 4 with SSRI 50mg equivalent, the dose should be increased to 100mg equivalent, although this is not directly cited, a related fact is that assessing at week 8 for adequate response is crucial 3

The American Psychiatric Association recommends that if inadequate response is seen after 8 weeks of optimized first-line treatment, evidence-based psychological intervention should be added to ongoing antidepressant before considering medication changes 3
The American College of Physicians suggests that augmentation options, such as adding bupropion SR 150-300mg daily or aripiprazole 2-15mg daily, have equivalent efficacy 5, 3

The National Center for Complementary and Integrative Health recommends considering omega-3 fatty acids, S-adenosyl-L-methionine, acupuncture, meditation, or yoga as adjunctive treatments to standard therapy 3
The American Herbal Products Association suggests avoiding St. John's wort due to significant drug-drug interactions despite efficacy evidence 3

The American College of Physicians recommends continuing antidepressant treatment for a minimum of 9-12 months after achieving remission to prevent relapse 2
The American Psychiatric Association suggests that maintenance treatment delays recurrence of depression in placebo-controlled trials, although this is not directly cited, a related fact is that tapering gradually rather than abrupt cessation minimizes discontinuation syndrome 2

The Agency for Healthcare Research and Quality recommends implementing systematic follow-up and outcome assessment using collaborative care models, which significantly improve treatment effectiveness 1
The American Medical Association suggests providing culturally informed and linguistically appropriate patient education about depression commonality, symptom patterns, and when to contact the medical team 1